Brivaracetam: First Global Approval.

about

Anticonvulsant drugs for generalized tonic-clonic epilepsy.

P2860

Q38798288-B7F7D1F6-BEC7-4EC2-88A9-A2F58FC29D9C

P2860

Brivaracetam: First Global Approval.

Item

http://www.wikidata.org/entity/Q38743281

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Brivaracetam: First Global Approval.

@en

type

Item

label

Brivaracetam: First Global Approval.

@en

prefLabel

Brivaracetam: First Global Approval.

@en

P1476

Brivaracetam: First Global Approval.

@en

P2093

Anthony Markham

http://www.w3.org/2001/XMLSchema#string

P2860

The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men

Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.

Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action.

Brivaracetam, a Novel Antiepileptic Drug: Is it Effective and Safe? Results from One Phase III Randomized Trial.

Adjunctive brivaracetam for refractory partial-onset seizures: a randomized, controlled trial.

Brivaracetam disposition in mild to severe hepatic impairment.

Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: a phase IIb, randomized, controlled trial.

A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures.

An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam.

Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.

P2888

s40265-016-0555-6

P304

517-522

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-016-0555-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1023267762

http://www.w3.org/2001/XMLSchema#string

P698

26899665

http://www.w3.org/2001/XMLSchema#string

P921

brivaracetam

Brivaracetam: First Global Approval.

about

P2860

P2860

Brivaracetam: First Global Approval.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921